Buy Vesugen 20mg: Synthetic Tripeptide Bioregulator for Vascular Endothelial Research

Buy Vesugen (20mg) is a synthetic tripeptide bioregulator (Lys-Glu-Asp, KED) studied for its targeted effects on vascular endothelial function and microcirculation. Current research explores its potential in ischemic tissue models and angiogenesis assays, where it demonstrates stabilization of vascular networks under hypoxic conditions, support for endothelial integrity, and modulation of vascular gene expression. This high-purity research peptide serves as a valuable tool for investigations into cardiovascular homeostasis, age-related vascular changes, and tissue perfusion in experimental settings.

Amino Acid Sequence: Lys-Glu-Asp (KED) Molecular Formula: C₁₅H₂₆N₄O₈ Molecular Weight: ≈390 g/mol Purity: ≥99% (lyophilized, research-grade)

Important Notice: This peptide is strictly intended for research and laboratory use only. Not for human consumption, diagnostic, therapeutic, or veterinary purposes. Please review and agree to our Terms and Conditions before ordering.

What is Vesugen?

Vesugen, also known as KED or T-38, is a short synthetic tripeptide developed in the lineage of Khavinson bioregulators. It is derived from sequences associated with vascular wall proteins and is investigated for its selective influence on endothelial cells lining blood vessels.

Preclinical and in-vitro studies suggest Vesugen interacts with promoter regions of genes like MKI67 (encoding proliferation marker Ki-67), potentially promoting endothelial cell proliferation, reducing polyploidy in aging models, and normalizing vascular signaling pathways.

Mechanism of Action in Research

In laboratory models, Vesugen is explored for:

• Enhancing microcirculation and blood flow regulation
• Supporting endothelial function and integrity
• Promoting angiogenesis and vascular network stabilization, especially under hypoxic or ischemic stress
• Modulating vascular inflammation and gene expression related to endothelial renewal
• Influencing epigenetic regulation in vascular tissues during aging

These properties make Vesugen a candidate for studies on hypoxia tolerance, tissue repair, and vascular resilience.

Key Research Areas and Potential Insights

Vesugen attracts attention in bioregulator and vascular biology research.

Vascular Endothelial Function and Microcirculation

Studies focus on its role in maintaining endothelial health, improving perfusion, and supporting capillary resistance in models of vascular aging or damage.

Ischemic and Hypoxic Tissue Models

Research examines Vesugen’s ability to stabilize vascular structures under low-oxygen conditions, potentially reducing hypoxia-induced damage and aiding tissue recovery.

Angiogenesis Assays

Investigations highlight its contribution to new vessel formation and network integrity, relevant for regenerative and ischemic disease models.

Broader Geroprotective and Cellular Effects

Additional explorations include vasoprotective actions in aging models, potential neuroprotective links via vascular pathways, and anabolic effects in chronic conditions.

Research Applications

The 20mg vial supports:

• In-vitro endothelial cell culture studies
• Models of ischemia, hypoxia, and angiogenesis
• Investigations into microcirculation, vascular permeability, and endothelial signaling
• Comparative bioregulator research with other Khavinson peptides

Reconstitution typically uses bacteriostatic water for precise dosing in experimental protocols.

Why Choose 99% Pure Vesugen 20mg?

Our Vesugen provides ≥99% purity for reliable, reproducible results in gene expression, cell proliferation, and vascular response assays. Third-party tested and lyophilized for maximum stability.

In summary, Vesugen 20mg is a premium synthetic tripeptide bioregulator for cutting-edge research into vascular endothelial function, microcirculation, ischemic tissue protection, angiogenesis, and hypoxia adaptation. Advance your vascular and regenerative studies with this specialized tool.

Latest Testing: Link to Report